Biokimia Farmasi: Metabolisme Lipid Part 1

Summary

The lecture introduces lipid metabolism, connecting the digestion and transport of fats to their storage, breakdown, energy production, and synthesis. It also explains cholesterol metabolism, statin drugs, and the health effects of abnormal blood lipid levels.

Main Ideas

What Lipids Do

• Lipids are generally insoluble in water but dissolve in organic solvents.
• They help form cell membranes, store energy, insulate the body, and serve as components or precursors of hormones and other biological molecules.
• Triacylglycerols (triglycerides) are the body’s main long-term energy store. The lecture notes that fat provides roughly twice as much energy per gram as carbohydrates.

Digestion, Absorption, and Transport

• Dietary fats are broken down mainly into fatty acids and glycerol-related products.
• Because fats do not dissolve in watery body fluids, they are transported in particles such as chylomicrons. These carry absorbed lipids from the intestine through the lymph and into the bloodstream, delivering them to tissues and the liver.
• LDL carries cholesterol from the liver toward tissues, while HDL carries cholesterol from tissues back toward the liver.

Storage and Release of Fat

• When energy intake exceeds immediate need, fatty acids can be joined to glycerol to form triglycerides and stored in adipose tissue. This process is called lipogenesis; the joining reaction is described as esterification.
• When energy is needed, triglycerides are broken down by lipolysis, releasing fatty acids and glycerol.
• Glycerol can enter pathways related to glycolysis or glucose formation. Fatty acids can be oxidized to produce acetyl-CoA and, ultimately, energy.

Fatty-Acid Synthesis and Breakdown

• Fatty-acid synthesis takes place in the cytosol, whereas in eukaryotic cells, fatty-acid breakdown mainly occurs in mitochondria.
• These processes are not simply reversals of each other: they use different enzymes and carrier molecules. Synthesis uses ACP and NADPH, while breakdown uses coenzyme A and produces reduced cofactors.
• In synthesis, carbon units are added to extend the fatty-acid chain. In beta-oxidation, the chain is shortened in two-carbon units, producing acetyl-CoA.
• The lecture outlines fatty-acid breakdown as a sequence of activation, transport into mitochondria using the carnitine system for long-chain fatty acids, and repeated cycles of oxidation, hydration, oxidation, and cleavage.
• Acetyl-CoA can enter the citric acid cycle or contribute to other pathways, including ketone-body or cholesterol formation.

Triglycerides and Phospholipids

• A triglyceride consists of glycerol joined to three fatty acids. Its breakdown releases the components for further metabolism.
• A phospholipid has a polar, water-attracting head and nonpolar, water-repelling tails. This amphipathic structure allows phospholipids to form membranes and bilayers.
• The lecture describes phosphatidic acid and related intermediates as part of triglyceride and phospholipid synthesis.

Ketone Bodies and Ketosis

• When carbohydrate availability is low or during prolonged fasting, the liver can convert excess acetyl-CoA into ketone bodies: acetoacetate, beta-hydroxybutyrate, and acetone.
• Ketone bodies can serve as fuel for other tissues. Excess production can cause ketosis and, in severe cases, ketoacidosis.
• The lecture links this risk to prolonged starvation, very restrictive or abnormal diets, and poorly controlled diabetes. It also mentions acetone breath or urine as possible signs.

Cholesterol and Statins

• Cholesterol is a component of cell membranes and a precursor for steroid hormones and bile acids.
• The lecture summarizes cholesterol synthesis as proceeding from acetyl-CoA through HMG-CoA and mevalonate, then through several intermediates to cholesterol.
• HMG-CoA reductase is identified as a key enzyme in this pathway. Statins such as simvastatin inhibit the enzyme, reducing cholesterol synthesis. The lecture also describes increased LDL uptake by the liver as part of the effect.
• The lecture notes that simvastatin is commonly taken in the evening because cholesterol synthesis is more active at night, while atorvastatin lasts longer and is less dependent on evening dosing.

Abnormal Lipids and Cardiovascular Risk

• The lecture distinguishes elevated cholesterol, elevated triglycerides, and mixed lipid abnormalities, and notes that these can have primary or secondary causes.
• Excess LDL can contribute to cholesterol deposits in artery walls, forming plaques that narrow arteries and may reduce blood flow. Blockage in coronary arteries can lead to a heart attack.
• HDL is presented as helping return cholesterol to the liver. The lecture emphasizes healthy eating and exercise as ways to support a healthier lipid profile.
• Blood testing is described as measuring total cholesterol, LDL, HDL, and triglycerides; the lecture advises fasting before testing. Specific numerical ranges in the subtitles appear garbled and are not reproduced here.

Activity and Next Steps

• The lecturer introduces nine trigger questions about lipid metabolism.
• Students are asked to answer them and submit their responses through Google Classroom.
• This first part provides an overview; a later video is said to cover the detailed metabolism of fatty acids and glycerol and energy calculations.

Speakers and Sources Featured

• Speaker: Shilla Rohman Rohim, identified in the opening as the lecturer and presenter.
• Source: PharmEdu Official.
• No other audible speakers are identifiable in the subtitles.